Term
|
Definition
MOST COMMON No identifiable cause |
|
|
Term
|
Definition
Results from underlying cause: Renal Dz Coarct of Aorta Hormonal Pregnancy |
|
|
Term
3 Objectives for pt w/ HTN |
|
Definition
1. Assess lifestyle and other CV risks 2. reveal identifiable causes 3. asses presence/absence of TOD and CVD |
|
|
Term
|
Definition
reduction of CV and renal morbidity |
|
|
Term
1st line of tx against HTN |
|
Definition
Lifestyle Mods -reduces BP -enhances drug effects -decr. CV risk |
|
|
Term
First line of DRUG therapy for most pts w/ HTN |
|
Definition
Thiazides ****Enhance efficacy of multidrug regimen**** Safe w/ ACEI/ARB, BB, and CCB's |
|
|
Term
2nd line of drug therapy for HTN |
|
Definition
**when single drug fails BP > 20/10 from goal -different class (ACEI/ARB, BB, CCB) |
|
|
Term
Once tx is initiate how often do you f/u |
|
Definition
monthly until BP goal is reached-> q 3-6 mos **more frequent if stage 2 or comorbids -monitor K and creatinine 2x/yr |
|
|
Term
Pts w/ DM and HTN are @ > risk of |
|
Definition
CV events **require more aggressive tx to prevent nephropathy, MI, stroke |
|
|
Term
|
Definition
BP > 220/130, with disc edema, TOD: severe perioperative HTN Goal: pt reduction BP with sx relief |
|
|
Term
|
Definition
HTN encephalopathy HTN nephropathy brain bleed aortic dissection preeclamp/eclamp pulm. edema unstable angina/MI |
|
|
Term
|
Definition
encephalopathy/nephropathy w/ papilledema ALWAYS REQUIRES IV DRUGS!! |
|
|
Term
initial goal of malignant HTN |
|
Definition
reduce BP by 25% w/i 1 hr and try for 160/110 w/i 2-6 hrs |
|
|
Term
4 major categories of drugs for HTN |
|
Definition
1. Diuretic 2 Sympatholytics 3. Angiotensin inhibitors 4. Vasodilators |
|
|
Term
|
Definition
1. Adrenergic receptor blockers: -BB, Alpha blockers 2. Centrally acting alpha 2 agonists |
|
|
Term
|
Definition
propranolol timolol nadolol pindolol |
|
|
Term
non-selective BB act where/how |
|
Definition
B1 and B2 receptors produce negative chronotropic, inotropic, and dromotropic effects |
|
|
Term
pindolol is different from other non-selective BB bc |
|
Definition
it has ISA (intrinsic sympathomimetic agonist) which can lower membrane-stabilizing activity ***only used to tx HTN*** |
|
|
Term
|
Definition
> affinity for B1 (less bronchospasm) *w/ incr dosage, can still block some B2's |
|
|
Term
|
Definition
d/t low ISA HTN, cardiac dysrhythmias Long DOA (oral) |
|
|
Term
Metoprolol metabolized by |
|
Definition
|
|
Term
|
Definition
IV for HTN and cardiac dysrythmias Short DOA |
|
|
Term
Alpha and beta adrenergic blockers |
|
Definition
|
|
Term
which alpha and beta blocker has antioxidant properties? |
|
Definition
carvedilol Cardioprotective in MI! |
|
|
Term
|
Definition
HTN more potent BB than alpha blocker (non-selective BB, A1 blocker) |
|
|